NVDA+2.54%AAPL+1.32%GOOGL−1.62%MSFT+0.20%AMZN−0.10%TSM+1.60%SPCX+7.79%META+0.47%
StockVS

NASDAQ · Pharmaceutical Retailers · USD

PetMed Express, Inc. (PETS) Stock Analysis

PetMed Express, Inc. (PETS) is a Pharmaceutical Retailers stock listed on NASDAQ and quoted in US Dollar.

Last Updated: October 21, 2026

PETS

$1.19

−$0.01 (−0.83%)

Oct 21, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare PETS with… →

PETS Key Statistics

As of Oct 21, 2026
Trading
Open
$1.21
Previous Close
$1.20
Day's Range
1.18–1.21
52-Week Range
1.15–4.10
Volume
62.66K
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
0.84
Valuation
Market Cap
$25.80M
P/E Ratio
unprofitable
PEG RatioThe P/E ratio divided by the expected earnings growth rate. It puts a high P/E in the context of how fast profits are growing.
2.32
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
0.15
EPS (ttm)Profit attributable to each share over the last twelve months.
−1.38
Financials (FY)
Revenue (FY)
$179.02M−34.69%
Net Income (FY)
−$57.29M
Profit marginThe share of revenue left as profit after all costs and taxes.
−17.34%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
21.68M
1-Year Return
−55.09%
Dividend and dates
Earnings Date
November 16, 2026estimated
Avg Volume
116.42K

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

Key facts

As of October 21, 2026, PETS closed at $1.19, −55.09% over 1 year.

PetMed Express, Inc. (PETS) has a market capitalization of $25.80M.

In fiscal 2025, PETS reported revenue of $179.02M.

PETS Stock Return by Calendar Year

PetMed Express, Inc. (PETS) 10-year return: what $10,000 became

1 year
$10,000 $4,491
−55.09%
5 years
$10,000 $500
−95.00%
10 years
$10,000 $780
−92.20%

If you had invested $10,000 in PetMed Express, Inc. (PETS) 10 years ago, at the close on October 21, 2016, it would have been worth $780 at the close on October 21, 2026: −92.20% in total, −22.51% a year, with dividends reinvested. A historical calculation from closing prices adjusted for splits and dividends, before fees and taxes.

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)−62.81%
2025−33.61%
2024−36.24%
2023−54.76%
2022−25.83%
2021−18.17%
2020+41.49%
2019+6.52%
2018−47.35%
2017+102.05%
2016 (partial year)+13.48%

As of October 21, 2026.

PETS Revenue and Earnings by Fiscal Year

FY ends March
Fiscal yearRevenueNet incomeNet margin
2025$179.02M−$57.29M−32.0%
2023$274.10M−$7.46M−2.7%
2022$247.57M$5.14M2.1%
2021$272.28M$18.72M6.9%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$179.02M$50.22M−$31.42M−$57.29M−32.0%
2023$274.10M$84.77M−$8.16M−$7.46M−2.7%
2022$247.57M$76.50M$6.05M$5.14M2.1%
2021$272.28M$76.94M$24.29M$18.72M6.9%

Annual figures as reported, in the company's reporting currency. As of March 31, 2026.

PETS Dividend History

$0.90−25.0% vs 2022

Dividends per share, 2023 · 3 payments

YearDividends per sharePaymentsChange
2023$0.903−25.0%
2022$1.204+1.7%
2021$1.184+6.3%
2020$1.114+2.8%
YearDividends per sharePaymentsChange
2023$0.903−25.0%
2022$1.204+1.7%
2021$1.184+6.3%
2020$1.114+2.8%
2019$1.084+3.8%
2018$1.044+31.6%
2017$0.794+315.8%
2016$0.191—

Most recent payment: $0.30 per share, ex-dividend August 11, 2023. Per-share amounts summed by calendar year from ex-dividend dates. Partial years are shown muted and marked with an asterisk.

PETS Valuation vs Pharmaceutical Retailers Median

Median of 6 stocks
MetricPETSPharmaceutical Retailers medianvs median
P/S ratio0.150.2437% below
Profit margin−17.34%−17.34%0.0 pts above

Medians across 6 Pharmaceutical Retailers stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of October 21, 2026.

Recent News

All 8 articles ↓

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

The market values PetMed Express, Inc. (PETS) at $25.80M. It is classified in the Pharmaceutical Retailers industry, within the Healthcare sector. The company reports 189 employees.

Over the past 52 weeks the price has ranged from $1.15 to $4.10. PETS last closed at $1.19 on October 21, 2026. That is −$0.01 (−0.83%) against the previous close. The latest close sits 3.48% above that 52-week low.

Financial Health

The most recent full year on file, fiscal 2025, shows revenue of $179.02M. That is −34.69% against the prior fiscal year, when revenue was $274.10M. The same year closed with a net loss of $57.29M. Profit margin runs at −17.34%. Earnings per share on a trailing basis come to −1.38.

Across the 4 fiscal years on file, revenue moves from $272.28M in 2021 to $179.02M in 2025. Of those 4 years, 2 report positive net income.

Valuation Assessment

No trailing P/E applies: the last reported earnings figure is negative. The PEG ratio, which sets the P/E against expected earnings growth, reads 2.32. The price-to-sales ratio is 0.15. On price-to-sales that is 37.24% below the Pharmaceutical Retailers median of 0.24. The medians here are taken across 6 Pharmaceutical Retailers companies that report the metric.

The trailing one-year total return is −55.09%. Across 10 years the annualized return works out at −22.51%. The reported beta is 0.84. Annualized volatility over the trailing 10 years is 63.24%.

Growth & Income

The dividend record for PETS runs through 2023. Dividends are recorded for 8 calendar years; 2023 shows 3 payments totalling $0.90 a share. The year before, 2022, totalled $1.20 a share.

The strongest complete calendar year on file is 2017 at +102.05%; the weakest is 2023 at −54.76%. Of the 9 complete calendar years on file, 3 finished higher. So far in 2026 the total return is −62.81%.

Peer Comparison

PetMed Express, Inc. (PETS) operates in the Pharmaceutical Retailers industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
PetMed Express, Inc. PETS $25.80M —
High Tide Inc. HITI $240.69M —
TelyRx Holdings Inc. TELY.TO CA$66.48M —
Pomdoctor Limited POM $27.90M —

Market caps are shown in each company's own trading currency, without conversion, and the peers are listed in order of these unconverted figures.

Every figure above is read from this page's own data on each daily rebuild. Informational only, not financial advice. As of October 21, 2026.

Related Pharmaceutical Retailers Stocks

HITI

High Tide Inc.

$240.69M

 TELY.TO

TelyRx Holdings Inc.

CA$66.48M

 POM

Pomdoctor Limited

$27.90M

 SCNX

Scienture Holdings, Inc.

$4.77M

 RDGT

Ridgetech, Inc.

$2.98M
View all Pharmaceutical Retailers stocks →

Popular Healthcare Stocks

LLY

Eli Lilly and Company

$1.13T

 JNJ

Johnson & Johnson

$621.22B

 ABBV

AbbVie Inc.

$503.27B

 UNH

UnitedHealth Group Incorporated

$374.30B

 MRK

Merck & Co., Inc.

$369.78B
View all Healthcare stocks →

About PetMed Express, Inc.

PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and household pet supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes. The company also sells food, beds, crates, stairs, and other pet supplies. It sells its products through its Internet website; mobile app; customer support center; and direct mail/print, which includes brochures and postcards. The company was incorporated in 1996 and is headquartered in Delray Beach, Florida.

Visit website →